Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


BioMarin Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to Valoctocogene Roxaparvovec, Investigational Gene Therapy for Hemophilia A


Benzinga | Mar 8, 2021 08:34AM EST

BioMarin Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to Valoctocogene Roxaparvovec, Investigational Gene Therapy for Hemophilia A






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC